Cambridge Investment Research Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-9,525
| Closed | -$394K | – | 3055 |
|
|
2022
Q1 | $394K | Sell |
9,525
-1,915
| -17% | -$79.2K | ﹤0.01% | 2305 |
|
|
2021
Q4 | $432K | Hold |
11,440
| – | – | ﹤0.01% | 2226 |
|
|
2021
Q3 | $377K | Buy |
11,440
+3,905
| +52% | +$129K | ﹤0.01% | 2266 |
|
|
2021
Q2 | $508K | Sell |
7,535
-2,115
| -22% | -$143K | ﹤0.01% | 2048 |
|
|
2021
Q1 | $546K | Buy |
+9,650
| New | +$546K | ﹤0.01% | 1838 |
|
|
2020
Q1 | – | Sell |
-2,603
| Closed | -$269K | – | 2284 |
|
|
2019
Q4 | $269K | Sell |
2,603
-8,072
| -76% | -$834K | ﹤0.01% | 1977 |
|
|
2019
Q3 | $216K | Sell |
10,675
-225
| -2% | -$4.55K | ﹤0.01% | 2060 |
|
|
2019
Q2 | $281K | Buy |
+10,900
| New | +$281K | ﹤0.01% | 1776 |
|